1. Home
  2. SFST vs RGNX Comparison

SFST vs RGNX Comparison

Compare SFST & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern First Bancshares Inc.

SFST

Southern First Bancshares Inc.

HOLD

Current Price

$58.07

Market Cap

429.7M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.97

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFST
RGNX
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.7M
418.1M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SFST
RGNX
Price
$58.07
$8.97
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$64.00
$28.75
AVG Volume (30 Days)
99.1K
560.1K
Earning Date
04-21-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
94.76
18.08
EPS
3.72
N/A
Revenue
$6,282,000.00
$10,393,000.00
Revenue This Year
$10.47
$50.15
Revenue Next Year
$12.19
$23.42
P/E Ratio
$15.70
N/A
Revenue Growth
12.99
126.48
52 Week Low
$30.68
$5.85
52 Week High
$62.00
$16.19

Technical Indicators

Market Signals
Indicator
SFST
RGNX
Relative Strength Index (RSI) 64.50 53.88
Support Level $50.36 $7.76
Resistance Level $58.77 $9.28
Average True Range (ATR) 1.61 0.52
MACD 0.67 0.15
Stochastic Oscillator 82.20 84.57

Price Performance

Historical Comparison
SFST
RGNX

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. Through its banking subsidiary, it is engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer, and mortgage loans, ATM processing, and other banking products and services to the general public. The group operates through various retail offices located in the Greenville, Columbia, and Charleston markets of South Carolina, three retail offices in the Raleigh, Greensboro, and Charlotte markets of North Carolina, and one retail office in Atlanta, Georgia.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: